Murphy Nicole 4
4 · BIOGEN INC. · Filed Feb 10, 2025
Insider Transaction Report
Form 4
BIOGEN INC.BIIB
Murphy Nicole
Head of Pharm Ops and Tech
Transactions
- Exercise/Conversion
Common Stock
2025-02-07+2,102→ 11,736.374 total - Tax Payment
Common Stock
2025-02-07$141.35/sh−620$87,637→ 11,116.374 total - Exercise/Conversion
Common Stock
2025-02-07+1,940→ 13,056.374 total - Tax Payment
Common Stock
2025-02-07$141.35/sh−603$85,234→ 12,453.374 total - Exercise/Conversion
Restricted Stock Unit
2025-02-07−1,940→ 3,880 totalExercise: $0.00Exp: 2027-02-07→ Common Stock (1,940 underlying) - Award
Restricted Stock Unit
2025-02-06+14,050→ 14,050 totalExercise: $0.00Exp: 2028-02-06→ Common Stock (14,050 underlying) - Exercise/Conversion
Restricted Stock Unit
2025-02-07−2,102→ 2,102 totalExercise: $0.00Exp: 2026-02-08→ Common Stock (2,102 underlying)
Footnotes (3)
- [F1]The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 6, 2025.
- [F2]The restricted stock units vest in three (3) equal annual installments commencing one year after the grant date of 02/8/2023.
- [F3]The restricted stock units vest in three (3) equal annual installments, commencing one year after the grant date of 02/07/2024.